Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections; A Cluster Randomized Feasibility Trial

NCT03223415 is registered in ClinicalTrials.gov with Yves Longtin as lead sponsor.

NCT NCT03223415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03223415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections; A Cluster Randomized Feasibility Trial
Lead sponsor
Yves Longtin
Phase
Not applicable
Overall status
Completed
Start date
August 25, 2017
Completion date
May 2, 2018
Enrollment
4,138 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile